Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XIAFLEX Dose Escalation for Lipoma
NCT01613313Phase 2Completed
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in lipoma. Started May 2012; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
lipoma
Beyond the preview
Go deeper on NCT01613313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613313.